SNHG10 expression was significantly associated with T stage (P = 0.013), N stage (P = 0.005), Gleason score (P < 0.001), primary therapy outcome (P < 0.001), and race (P = 0.008), while patients of different ages, M stage, residual tumor, zone of origin, and PSA shown no significant difference (Table 1). The gene discussed is SNHG10; the disease is neoplasm.